53 related articles for article (PubMed ID: 31619064)
1. Feasibility and Clinical Significance of In Vivo Cholesterol Crystal Detection Using Optical Coherence Tomography.
Katayama Y; Tanaka A; Taruya A; Kashiwagi M; Nishiguchi T; Ozaki Y; Matsuo Y; Kitabata H; Kubo T; Shimada E; Kondo T; Akasaka T
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):220-229. PubMed ID: 31619064
[TBL] [Abstract][Full Text] [Related]
2. The impact of statins treatments for plaque characteristics in stable angina pectoris patients with very low and high low-density lipoprotein cholesterol levels: an intracoronary optical coherence tomography study.
Amano H; Kojima Y; Hirano S; Oka Y; Aikawa H; Noike R; Yabe T; Okubo R; Ikeda T
Heart Vessels; 2024 Jun; 39(6):475-485. PubMed ID: 38381169
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol crystal depth in coronary atherosclerotic plaques: A novel index of plaque vulnerability using optical frequency domain imaging.
Koide M; Matsuo A; Shimoo S; Takamatsu K; Kyodo A; Tsuji Y; Mera K; Tsubakimoto Y; Isodono K; Sakatani T; Inoue K; Fujita H
PLoS One; 2017; 12(6):e0180303. PubMed ID: 28665970
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol crystals at the culprit lesion in patients with acute coronary syndrome are associated with worse cardiovascular outcomes at two years follow up - results from the translational OPTICO-ACS study program.
Nelles G; Abdelwahed YS; Seppelt C; Meteva D; Stähli BE; Rai H; Seegers LM; Sieronski L; Musfeldt J; Gerhardt T; Riedel M; Skurk C; Haghikia A; Sinning D; Dreger H; Knebel F; Trippel TD; Krisper M; Klotsche J; Joner M; Landmesser U; Leistner DM
Int J Cardiol; 2024 Mar; 399():131665. PubMed ID: 38141724
[TBL] [Abstract][Full Text] [Related]
5. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography.
Jang IK; Tearney GJ; MacNeill B; Takano M; Moselewski F; Iftima N; Shishkov M; Houser S; Aretz HT; Halpern EF; Bouma BE
Circulation; 2005 Mar; 111(12):1551-5. PubMed ID: 15781733
[TBL] [Abstract][Full Text] [Related]
6. Combining metabolomics and OCT to reveal plasma metabolic profiling and biomarkers of plaque erosion and plaque rupture in STEMI patients.
Luo X; Liu M; Wang S; Chen Y; Bao X; Lv Y; Zhang S; Xu B; Weng X; Bai X; Zeng M; Zhao C; Li J; Jia H; Yu B
Int J Cardiol; 2023 Nov; 390():131223. PubMed ID: 37517782
[TBL] [Abstract][Full Text] [Related]
7. Plaque burden influences accurate classification of fibrous cap atheroma by in vivo optical coherence tomography in a porcine model of advanced coronary atherosclerosis.
Poulsen CB; Pedrigi RM; Pareek N; Kilic ID; Holm NR; Bentzon JF; Bøtker HE; Falk E; Krams R; de Silva R
EuroIntervention; 2018 Nov; 14(10):1129-1135. PubMed ID: 29616625
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol Crystals as the Main Trigger of Interleukin-6 Production through Innate Inflammatory Response in Human Spontaneously Ruptured Aortic Plaques.
Komatsu S; Yutani C; Takahashi S; Takewa M; Iwa N; Ohara T; Kodama K
J Atheroscler Thromb; 2023 Nov; 30(11):1715-1726. PubMed ID: 37081615
[TBL] [Abstract][Full Text] [Related]
9. Different Characteristics and Interleukin-6 Ratios of Scattering-Type Aortic Plaques.
Komatsu S; Yutani C; Takahashi S; Ohara T; Iwa N; Takewa M; Noda H; Kodama K
Cureus; 2024 Jan; 16(1):e52949. PubMed ID: 38274622
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol Crystal Embolism in a Patient with Spontaneous Ruptured Aortic Plaques Identified by Non-Obstructive General Angioscopy.
Koyama Y; Kojima K; Abe M; Okumura Y
Int Heart J; 2024; 65(3):586-590. PubMed ID: 38825500
[TBL] [Abstract][Full Text] [Related]
11. Formation and Cellular Impact of Cholesterol Crystals in Health and Disease.
Baumer Y; McCurdy SG; Boisvert WA
Adv Biol (Weinh); 2021 Nov; 5(11):e2100638. PubMed ID: 34590446
[TBL] [Abstract][Full Text] [Related]
12. The effect of colchicine on cholesterol crystal formation, expansion and morphology: a potential mechanism in atherosclerosis.
Abideen ZU; Pathak DR; Sabanci R; Manu M; Abela GS
Front Cardiovasc Med; 2024; 11():1345521. PubMed ID: 38495937
[TBL] [Abstract][Full Text] [Related]
13. Effect of aspirin on cholesterol crystallization: A potential mechanism for plaque stabilization.
Fry L; Lee A; Khan S; Aziz K; Vedre A; Abela GS
Am Heart J Plus; 2022 Jan; 13():100083. PubMed ID: 38560074
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol crystals induce mechanical trauma, inflammation, and neo-vascularization in solid cancers as in atherosclerosis.
Abela GS; Katkoori VR; Pathak DR; Bumpers HL; Leja M; Abideen ZU; Boumegouas M; Perry D; Al-Janadi A; Richard JE; Barnaba C; Meza IGM
Am Heart J Plus; 2023 Nov; 35():. PubMed ID: 37981958
[TBL] [Abstract][Full Text] [Related]
15. Detection of cholesterol crystals by optical coherence tomography.
Jinnouchi H; Sato Y; Torii S; Sakamoto A; Cornelissen A; Bhoite RR; Kuntz S; Guo L; Paek KH; Fernandez R; Kolodgie FD; Virmani R; Finn AV
EuroIntervention; 2020 Aug; 16(5):395-403. PubMed ID: 32310132
[TBL] [Abstract][Full Text] [Related]
16. Micro Optical Coherence Tomography for Coronary Imaging.
Nishimiya K; Tearney G
Front Cardiovasc Med; 2021; 8():613400. PubMed ID: 33842560
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography detection of vulnerable plaques at high risk of developing acute coronary syndrome.
Kubo T; Ino Y; Mintz GS; Shiono Y; Shimamura K; Takahata M; Terada K; Higashioka D; Emori H; Wada T; Kashiwagi M; Tanimoto T; Tanaka A; Hozumi T; Akasaka T
Eur Heart J Cardiovasc Imaging; 2021 Feb; ():. PubMed ID: 33619524
[TBL] [Abstract][Full Text] [Related]
18. Impact of Optical Coherence Tomography Imaging on Decision-Making During Percutaneous Coronary Intervention in Patients Presented With Acute Coronary Syndromes.
Khalifa AKM; Kubo T; Shimamura K; Ino Y; Kishk YT; Hasan-Ali H; Abdel-Galeel A; Terada K; Emori H; Higashioka D; Takahata M; Shiono Y; Akasaka T
Circ J; 2021 Sep; 85(10):1781-1788. PubMed ID: 33473095
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Laboratory Predictors for Plaque Erosion in Patients With Acute Coronary Syndromes.
Yamamoto E; Yonetsu T; Kakuta T; Soeda T; Saito Y; Yan BP; Kurihara O; Takano M; Niccoli G; Higuma T; Kimura S; Minami Y; Ako J; Adriaenssens T; Boeder NF; Nef HM; Fracassi F; Sugiyama T; Lee H; Crea F; Kimura T; Fujimoto JG; Fuster V; Jang IK
J Am Heart Assoc; 2019 Nov; 8(21):e012322. PubMed ID: 31640466
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of low-intensity area without attenuation and cholesterol crystals in non-culprit lesions assessed by optical coherence tomography.
Usui E; Matsumura M; Mintz GS; Zhou Z; Hada M; Yamaguchi M; Hoshino M; Kanaji Y; Sugiyama T; Murai T; Lee T; Yonetsu T; Kakuta T; Kunio M; Tearney GJ; Maehara A
Atherosclerosis; 2021 Sep; 332():41-47. PubMed ID: 34384955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
